glp-1 obesity drug news today 2025 A nice article in The Hindu today highlights the GLP-1 Agonists For Obesity In

In a gut slowed by medications like Ozempic, expanding fiber can cause severe bloating or blockages

In order to develop exendin-4 as a drug Amylin set about synthesising the peptide from the Gila monster and then testing it

CoverWell provides protection during this uncertainty

[DOI] [PubMed] [Google Scholar] 56.Batista AF, et al

doi: 10.1016/j.metop.2024.100283 22 WildingJPHBatterhamRLDaviesMVan GaalLFKandlerKKonakliKet al

By stimulating glucose-dependent insulin secretion and suppressing glucagon production, they are a cornerstone of the treatment of type 2 diabetes (DM2), particularly in patients with a higher risk of cardiovascular disease ( This narrative review describes the complex interplay between GLP-1 signalling and intestinal inflammation, highlighting both the potential benefits and limitations of GLP1 RAs in IBD management, with a particular focus on their promising role in selected obese IBD patients